Jatinder Kumar Sharda

Jatinder Kumar Sharda

Active Director Director DIN 03032727
DIN 03032727 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 7 historical roles
Total affiliations 10 Since Mar 2012
Shareholding value •••• Premium profile

About Jatinder Kumar Sharda

Data last updated:

Jatinder Kumar Sharda is a Director at Biopolis Lifesciences Private Limited (since 2018), Director at Britmed Healthcare Private Limited (since 2025) and Director at Ultrapolis Lifesciences Private Limited (since 2022). The companies operate in Pharma, Food And Beverages and Chemicals. The largest current company by reported revenue is Biopolis Lifesciences Private Limited at ₹11.24 Cr (FY 2024). Earlier, Jatinder Kumar Sharda was a Director at Aclivia Healthcare Private Limited (2022–2025) and Director at One Wellness International Private Limited (2020–2025) and 5 more.

DIN 03032727
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2012
Oldest Company Age 14 yrs
Largest company Biopolis Lifesciences Private Limited · ₹11.24 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20182018₹11.24 Cr (FY 2024)Active
Britmed Healthcare Private Limited U46497HR2025PTC138696
Director03 Dec 20252025Active
Director02 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aclivia Healthcare Private Limited U24290HR2022PTC108178
Director06 Dec 20222022Active
Director29 Aug 20202020₹4.10 Cr (FY 2025)Active
Derma 360 Private Limited U24100HR2022PTC100850
Director27 Jan 20222022₹4.14 Cr (FY 2025)Active
Director08 Nov 20232019₹11.60 Cr (FY 2025)Active
Healthgate Private Limited U24290HR2022PTC100853
Director27 Jan 20222022₹7.63 Cr (FY 2025)Active
Abibba Pharmaa Private Limited U24232CH2014PTC034927
Director27 May 20142014₹4.24 Cr (FY 2025)Active
Partner30 Mar 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biopolis Lifesciences Private Limited
Meditrain Pharma Business School Llp
Ultrapolis Lifesciences Private Limited
Britmed Healthcare Private Limited
Premium access

Shareholding and investment profile for Jatinder Kumar Sharda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jatinder Kumar Sharda

Jatinder Kumar Sharda currently holds 3 directorships: Biopolis Lifesciences Private Limited (Director, since 25 Sep 2018, revenue ₹11.24 Cr (FY 2024)); Britmed Healthcare Private Limited (Director, since 03 Dec 2025); Ultrapolis Lifesciences Private Limited (Director, since 02 Dec 2022).

Jatinder Kumar Sharda was first appointed on 30 Mar 2012 as Partner at Meditrain Pharma Business School Llp. The most recent appointment on record is 03 Dec 2025 at Britmed Healthcare Private Limited.

Jatinder Kumar Sharda held 7 earlier board appointments: Aclivia Healthcare Private Limited (Director, 06 Dec 2022 to 22 Dec 2025); One Wellness International Private Limited (Director, 29 Aug 2020 to 25 Jun 2025); Derma 360 Private Limited (Director, 27 Jan 2022 to 23 Jun 2025); Micropolis Lifesciences Private Limited (Director, 08 Nov 2023 to 24 Jun 2025); Healthgate Private Limited (Director, 27 Jan 2022 to 24 Feb 2023); and 2 more.

The current boards of Jatinder Kumar Sharda's companies include Abhinav Sharda (Biopolis Lifesciences Private Limited), Mandeepika (Biopolis Lifesciences Private Limited), Mridul Aggarwal (Britmed Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available